Prosecution Insights
Prosecution Insights
Listed by the USPTO as AZPURU, CARLOS A
Tech Center 3700 • Art Units: 1611 1612 1615 1616 1617 3774
This examiner grants 84% of resolved cases
Carlos A. Azpuru is a patent examiner in Tech Center 3700 and Art Unit 1611. He has managed 1298 resolved cases. The allowance rate for these cases is 83.7%. The median days to allowance for these cases is 965. An interview lift of 10.8% is also present in the data.
Practitioners can use the 1298 resolved cases to understand the examiner's experience level. The 83.7% allowance rate provides a probability for success in this art unit. The 965 median days to allowance offers a timeline for planning prosecution cycles. The 10.8% interview lift shows the increase in the probability of allowance after an interview.
Top companies like The Procter & Gamble Company, Ocular Therapeutix Inc., and University of Southern California appear in the records. Firms like FOLEY & LARDNER LLP and BakerHostetler have handled these 1298 resolved cases. Best & Flanagan LLP is also a top firm in this examiner's history. These entities interact with the 83.7% allowance rate and the 965-day median pendency. The 10.8% interview lift suggests that practitioners should consider an interview as a tactical option.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18733177 | DEODORANT AND ANTIPERSPIRANT COMPOSITIONS | Non-Final OA | The Procter & Gamble Company |
| 18443360 | COSMETIC INK COMPOSITION COMPRISING A SURFACE TENSION MODIFIER | Non-Final OA | The Procter & Gamble Company |
| 18790605 | SYSTEM AND METHOD OF ATTACHING SOFT TISSUE TO AN IMPLANT | Non-Final OA | PURDUE RESEARCH FOUNDATION |
| 18325567 | SUSTAINED FORMULATION FOR PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASE CONTAINING NALTREXONE AND METHOD USING THE SAME | Non-Final OA | INVENTAGE LAB INC. |
| 18695487 | COMPOSITIONS AND METHODS FOR T CELL TARGETED DELIVERY OF THERAPEUTIC AGENTS | Non-Final OA | The Trustees Of The University of Pennsylvania |
| 18824295 | NUCLEIC ACID NANOSHELLS FOR CO-DELIVERING PROTEINS AND PROTEIN-CONTAINING COMPOUNDS AND METHODS OF MANUFACTURING NUCLEIC ACID NANOSHELLS CONTAINING PROTEINS AND PROTEIN-CONTAINING COMPOUNDS | Non-Final OA | Howard University |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy83.7% of resolved applications examined by Carlos A Azpuru were allowed (1,298 resolved cases), compared with 35.0% across Art Unit 1611 over the last five years.
This examiner's interview lift is +10.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Carlos A Azpuru took 965 days on average from filing to allowance.
Carlos A Azpuru examines applications in Art Unit 1611 in Tech Center 3700 (Medical Devices & Mechanical Engineering).